Phio Pharmaceuticals Corp
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
11.6M
on 2026-06-30, from 510K on 2024-03-31 10-Q ↗
Earlier counts are adjusted for the 1-for-9 reverse split; each bar's tip shows the count as filed.
a raise that quarter, at its price
Newest
S-3 of 2024-05-20. Not read yet. S-3 ↗
$6.4M
H.C. Wainwright, agreement of 2026-04-08. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗
Warrants
13.39M
Warrants of every class as tagged in the XBRL facts on 2026-06-30, exercise price $2.86. 10-Q ↗
Cash
4.3 quarters
$13.0M on 2026-06-30 ÷ $3.1M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2025-01-16 | Public offering | 610,000 | $3.00 | $1.8M | 424B5 ↗ |
| 2025-01-14 | Public offering | 833,335 | $3.00 | $2.5M | 424B5 ↗ |
| 2025-01-13 | Public offering | 1,063,670 | $3.00 | $3.2M | 424B5 ↗ |